Premium
The selective therapeutic apheresis procedures
Author(s) -
Sanchez Amber P.,
Cunard Robyn,
Ward David M.
Publication year - 2013
Publication title -
journal of clinical apheresis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.697
H-Index - 46
eISSN - 1098-1101
pISSN - 0733-2459
DOI - 10.1002/jca.21265
Subject(s) - immunoadsorption , plasmapheresis , apheresis , medicine , ldl apheresis , extracorporeal , photopheresis , clotting factor , intensive care medicine , antibody , surgery , immunology , platelet , lymphoma
Selective apheresis procedures have been developed to target specific molecules, antibodies, or cellular elements in a variety of diseases. The advantage of the selective apheresis procedures over conventional therapeutic plasmapheresis is preservation of other essential plasma components such as albumin, immunoglobulins, and clotting factors. These procedures are more commonly employed in Europe and Japan, and few are available in the USA. Apheresis procedures discussed in this review include the various technologies available for low‐density lipoprotein ( LDL ) apheresis, double filtration plasmapheresis ( DFPP ), cryofiltration, immunoadsorption procedures, adsorption resins that process plasma, extracorporeal photopheresis, and leukocyte apheresis. J. Clin. Apheresis 28:20–29, 2013. © 2013 Wiley Periodicals, Inc.